Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Current Rheumatology Reports
|
April 24, 2016
Urate Handling in the Human Body
David Hyndman, Sha Liu, Jeffrey N Miner
Radiology Case Reports
|
September 8, 2023
CT diagnosis and laparoscopic treatment of hepatic abscess secondary to fish bone transmigration through the stomach wall
David Hyndman, Ranjit Chaudhary, Shawna Kettyle, et al.
Nature
|
December 12, 2019
Groundwater: a call to action
Tom Gleeson, Karen Villholth, Richard Taylor, et al.
Chemico-Biological Interactions
|
February 27, 2003
The aldo-keto reductase superfamily homepage
David Hyndman, David R Bauman, Vladi V Heredia, et al.
Biology of Reproduction
|
April 11, 2008
RAB2A: a major subacrosomal protein of bovine spermatozoa implicated in acrosomal biogenesis
Jeremi R Mountjoy, Wei Xu, Dave McLeod, et al.
Water Research
|
May 22, 2022
Connecting microbial, nutrient, physiochemical, and land use variables for the evaluation of water quality within mixed use watersheds
Matthew T Flood, J Sebastian Hernandez-Suarez, A Pouyan Nejadhashemi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 8, 2004
Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors
Anne-Marie Lefrançois-Martinez, Jérôme Bertherat, Pierre Val, et al.
Cancer Gene Therapy
|
February 22, 2002
VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice
Masako Kamiyama, Yasushi Ichikawa, Takashi Ishikawa, et al.
Arthritis Research & Therapy
|
October 8, 2016
Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney
Jeffrey N Miner, Philip K Tan, David Hyndman, et al.
Arthritis Research & Therapy
|
October 14, 2016
Erratum to: Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney
Jeffrey N Miner, Philip K Tan, David Hyndman, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Current Rheumatology Reports
|
April 24, 2016
Urate Handling in the Human Body
David Hyndman, Sha Liu, Jeffrey N Miner
Radiology Case Reports
|
September 8, 2023
CT diagnosis and laparoscopic treatment of hepatic abscess secondary to fish bone transmigration through the stomach wall
David Hyndman, Ranjit Chaudhary, Shawna Kettyle, et al.
Nature
|
December 12, 2019
Groundwater: a call to action
Tom Gleeson, Karen Villholth, Richard Taylor, et al.
Chemico-Biological Interactions
|
February 27, 2003
The aldo-keto reductase superfamily homepage
David Hyndman, David R Bauman, Vladi V Heredia, et al.
Biology of Reproduction
|
April 11, 2008
RAB2A: a major subacrosomal protein of bovine spermatozoa implicated in acrosomal biogenesis
Jeremi R Mountjoy, Wei Xu, Dave McLeod, et al.
Water Research
|
May 22, 2022
Connecting microbial, nutrient, physiochemical, and land use variables for the evaluation of water quality within mixed use watersheds
Matthew T Flood, J Sebastian Hernandez-Suarez, A Pouyan Nejadhashemi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 8, 2004
Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors
Anne-Marie Lefrançois-Martinez, Jérôme Bertherat, Pierre Val, et al.
Cancer Gene Therapy
|
February 22, 2002
VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice
Masako Kamiyama, Yasushi Ichikawa, Takashi Ishikawa, et al.
Arthritis Research & Therapy
|
October 8, 2016
Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney
Jeffrey N Miner, Philip K Tan, David Hyndman, et al.
Arthritis Research & Therapy
|
October 14, 2016
Erratum to: Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney
Jeffrey N Miner, Philip K Tan, David Hyndman, et al.
Page
of 1